Skip to content

SCLX

Scilex Holding Co

NASDAQ · Healthcare · Drug Manufacturers - General · US

$5.04
−6.15%
Ask drillr

Next report

Analyst consensus

Next report date
Dec 2, 2026
EPS estimate
-$0.08
Revenue estimate
$17.0M

Latest reported

Last report date
Aug 14, 2026
EPS actual
-$17
EPS estimate
-$0.18
Revenue actual
$7.6M
Revenue estimate
$16.0M

Track record

Trailing twelve quarters

EPS beats (12Q)
0
EPS misses (12Q)
7
EPS in line (12Q)
0
Avg surprise (4Q)
-4180.3%
Revenue beats (12Q)
1
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 14, 2026-$0.18-$17Miss -9083.17%$7.6M
May 20, 2026-$0.34-$4.76Miss -1311.21%$8.6M
Nov 14, 2025-$0.47-$22Miss -4617.02%$10.6M
Aug 13, 2025-$0.41-$7.42Miss -1709.76%$9.9M
Mar 31, 2025-$0.10-$0.25Miss -150.00%$14.9M
Mar 11, 2024-$7.34-$8.74Miss -19.07%$13.5M
Nov 14, 2023-$5.94-$22Miss -270.88%$10.1M
Aug 11, 2023-$5.59$12.6M
May 12, 2023-$0.22$10.6M
Mar 7, 2023-$4.66$11.9M
Jun 30, 2022-$4.42$7.9M
Mar 31, 2022-$2.27$6.8M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026